Launch Vic Collaboration (July 2016)
July 2016 BioMelbourne Network CEO, Dr Krystal Evans, met with the CEO of Launch Vic Dr Pradeep Philip to discuss ways to support start-ups and entrepreneurial activity in the biotech, medtech and pharma sector. The goals of Launch…
Meeting with the Hon Wade Noonan MP
July 2016 BioMelbourne Network CEO, Dr Krystal Evans and Chair, Mr Andrew Carter held an introductory meeting with the Hon Wade Noonan, Minister for Industry and Employment. Minister Noonan was appointed into this role in May and has…
Two new strategies launched (July 2016)
July 2016 In July, Victorian Health Minister Jill Hennessy launched two new government strategies: Victoria’s Health and Medical Research Strategy 2016-20: Healthier lives, stronger economy Victoria’s International Health Strategy 2016 – 2020: Partnering for a healthy and prosperous future…
NISA Engagement and Impact Assessment Consultation Paper
June 2016 BioMelbourne Network welcomed the opportunity to contribute a submission in response to the National Innovation & Science Agenda (NISA) Engagement and Impact Assessment Consultation Paper. Research engagement and impact is a very important issue for BioMelbourne…
Curtin Medal recognises Institute director’s contributions to medical researc
1st July, 2016 – Professor Doug Hilton, director of the Walter and Eliza Hall Institute, has been awarded The Curtin Medal for Excellence in Medical Research for his outstanding contributions to medical science. The award from The John…
CSIRO and 360BioLabs who have been successful in securing a CRC-P grant to develop an antibody based in vitro diagnostic for metastatic cancer
Congratulations to to BioMelbourne Network members – CSIRO and 360BioLabs – who have been successful in securing a CRC-P grant to develop an antibody based in vitro diagnostic for metastatic cancer. This is the first round of the…
‘Holy grail’ of breast cancer prevention in high-risk women may be in sight
June 21st, 2016 Walter and Eliza Hall Institute researchers have discovered that an existing medication could have promise in preventing breast cancer in women carrying a faulty BRCA1 gene. This could mean that women with high genetic risk…
MRFF Submission (June 2016)
June 2016 The MRFF will be used to drive medical innovation, and is a massive opportunity to boost research translation and accelerate the development of discoveries into clinical reality in Australia. The Australian Medical Research Advisory Board held…
Retiring LBT Innovations CEO Lusia Guthrie Appointed Chair of Clever Culture Systems AG
Adelaide, Australia, 10 June 2016: The co-founder and Chief Executive of Australian laboratory automation company LBT Innovations Limited (LBT), Mrs Lusia Guthrie, has been appointed Chair of Clever Culture Systems AG (CCS) for a 2-year period from June…
Roundtable Discussion: The Biotech and Medtech Startup Ecosystem (June 2016)
June 2016 BioMelbourne Network in partnership with Allens hosted a roundtable with the Hon Phillip Dalidakis Minister for Small Business, Innovation and Trade on the 20th of June to discuss the biotech and medtech startup ecosystem. Minister Dalidakis…
Updated clinical trial data on CAVATAK™ tumour targeting and immune-activation presented at the American Society Clinical Oncology (ASCO) Annual Meeting
6 June 2016, Sydney, Australia: Viralytics Limited(ASX: VLA, OTC: VRACY) today announced that it has presented posters updating the results of the ongoing Phase 1 STORM/KEYNOTE 200 and the completed Phase 2 CALM clinical trials of Viralytics’ lead…
Melbourne And Boston Strike New Health Agreements
Premier Daniel Andrews today visited the Boston Children’s Hospital as part of his official US visit, announcing a new partnership with Victoria’s Royal Children’s Hospital in Melbourne.As two of the world’s leading children’s hospitals, the Boston and Royal…
